|
| Press Releases |
|
 |
|
| Friday, February 14, 2025 |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| more info >> |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
| Friday, January 24, 2025 |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| more info >> |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
| Thursday, January 9, 2025 |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
| Monday, December 9, 2024 |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
| Monday, December 2, 2024 |
|
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
| China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
| China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Galaxy Payroll Group and Euler Number Limited Announce Strategic Partnership to Transform HR and Payroll Solutions
Feb 28, 2025 22:17 HKT/SGT
|
|
|
曹操智行自動駕駛平台上線 構建國內首個"F立方"全域自研閉環智駕生態
Feb 28, 2025 19:11 HKT/SGT
|
|
|
Q2 Metals Announces Warrant Exercise for $7.6 Million
Feb 28, 2025 18:38 HKT/SGT
|
|
|
曹操智行自动驾驶平台上线 构建国内首个"F立方"全域自研闭环智驾生态
Feb 28, 2025 18:35 HKT/SGT
|
|
|
持續深耕國際市場 乘用車頭部企業奇瑞汽車遞交港股上市申請
Feb 28, 2025 18:14 HKT/SGT
|
|
|
Galaxy Payroll Group and Euler Number Limited Announce Strategic Partnership to Transform HR and Payroll Solutions
Feb 28, 2025 18:04: JST
|
|
|
AEON Credit Secures HK$300 Million Syndicated Sustainability-Linked Loan
Feb 28, 2025 17:55 HKT/SGT
|
|
|
AEON信貸財務獲3億港元可持續發展表現掛鈎銀團貸款
Feb 28, 2025 17:44 HKT/SGT
|
|
|
AEON信贷财务获3亿港元可持续发展表现挂钩银团贷款
Feb 28, 2025 17:30 HKT/SGT
|
|
|
Fujitsu's Oyama plant achieves top CSR score for sustainability in global telecom audit
Feb 28, 2025 16:57 JST
|
|
|
HKTDC welcomes Hong Kong SAR's 2025-26 Budget
Feb 28, 2025 15:54 HKT/SGT
|
|
|
Honda、軽二輪スーパースポーツモデル「CBR250RR」のカラーバリエーションを変更し発売
Feb 28, 2025 15:00: JST
|
|
|
三菱重工、ポジティブ・インパクト・ファイナンス融資契約を締結
Feb 28, 2025 15:00: JST
|
|
|
The 17th Annual Global CSR & ESG Summit 2025 Concludes in Ho Chi Minh City, Setting New Standards in Sustainability
Feb 28, 2025 11:56: JST
|
|
|
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone
Feb 28, 2025 12:31 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
